Bharat Biotech to conduct Covaxin clinical trials in US

Hyderabad-based Bharat Biotech said on Friday that it will be carrying out a clinical trial in the US to support the marketing application for Covaxin in that country. The company didn’t disclose details regarding the possible number of participants or whether it would be a local bridging trial, among other details.
On Thursday the US partner for Bharat Biotech’s Covid-19 vaccine, Ocugen, said that it would pursue submission of a Biologics License Application (BLA) for the jab, instead of seeking Emergency Use Authorisation (EUA) as originally planned.